{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:39:21Z","timestamp":1784947161798,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010662","name":"Horizon Europe Excellent Science","doi-asserted-by":"publisher","award":["G101558"],"award-info":[{"award-number":["G101558"]}],"id":[{"id":"10.13039\/100010662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018509","name":"National Spectrum Consortium","doi-asserted-by":"publisher","award":["G101558"],"award-info":[{"award-number":["G101558"]}],"id":[{"id":"10.13039\/100018509","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019326","name":"UK Regenerative Medicine Platform","doi-asserted-by":"publisher","award":["MR\/S020934\/1"],"award-info":[{"award-number":["MR\/S020934\/1"]}],"id":[{"id":"10.13039\/501100019326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003343","name":"Cambridge Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020400","name":"John Black Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Stem Cell Reports"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.stemcr.2026.102818","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:11:53Z","timestamp":1770912713000},"page":"102818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The immunological profile of RC17 hESC-derived dopaminergic neural progenitor cells in vitro: Implications for the STEM-PD clinical trial"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9105-1131","authenticated-orcid":false,"given":"Annabel J.","family":"Curle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaline V.","family":"Fazal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamma","family":"Qarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Howlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athena","family":"Stamper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkat","family":"Pisupati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger A.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4974-1371","authenticated-orcid":false,"given":"Joanne L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.stemcr.2026.102818_bib1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0025-6196(12)62532-4","article-title":"Adrenal medullary transplantation into the brain for treatment of Parkinson\u2019s disease: Clinical outcome and neurochemical studies","volume":"65","author":"Ahlskog","year":"1990","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.stemcr.2026.102818_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3171\/jns.1985.62.2.0169","article-title":"Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials","volume":"62","author":"Backlund","year":"1985","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.stemcr.2026.102818_bib3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s41591-019-0507-2","article-title":"Designing stem-cell-based dopamine cell replacement trials for Parkinson\u2019s disease","volume":"25","author":"Barker","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.stemcr.2026.102818_bib4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1474-4422(12)70295-8","article-title":"Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson\u2019s disease","volume":"12","author":"Barker","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.stemcr.2026.102818_bib5","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nrneurol.2015.123","article-title":"Cell-based therapies for Parkinson disease\u2014Past insights and future potential","volume":"11","author":"Barker","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.stemcr.2026.102818_bib6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41587-025-02567-2","article-title":"The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson\u2019s disease","volume":"44","author":"Barker","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.stemcr.2026.102818_bib7","doi-asserted-by":"crossref","first-page":"15017","DOI":"10.1038\/npjparkd.2015.17","article-title":"G-Force PD: A global initiative in coordinating stem cell-based dopamine treatments for Parkinson\u2019s disease","volume":"1","author":"Barker","year":"2015","journal-title":"NPJ Parkinson's Dis."},{"key":"10.1016\/j.stemcr.2026.102818_bib8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1242\/dev.099937","article-title":"Reelin and CXCL12 regulate distinct migratory behaviors during the development of the dopaminergic system","volume":"141","author":"Bodea","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.stemcr.2026.102818_bib9","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/brain\/123.7.1380","article-title":"Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson\u2019s disease","volume":"123","author":"Brundin","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.stemcr.2026.102818_bib10","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1016\/j.cell.2025.09.010","article-title":"Phase 1\/2a clinical trial of hESC-derived dopamine progenitors in Parkinson\u2019s disease","volume":"188","author":"Chang","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.stemcr.2026.102818_bib11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/REP-20-0215","article-title":"Pluripotent stem cells are insensitive to the cytotoxicity of TNF\u03b1 and IFN\u03b3","volume":"160","author":"Chen","year":"2020","journal-title":"Reproduction"},{"key":"10.1016\/j.stemcr.2026.102818_bib12","author":"Curle"},{"key":"10.1016\/j.stemcr.2026.102818_bib13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.stemcr.2026.102818_bib14","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.3233\/JPD-212920","article-title":"Human Embryonic Stem Cell-Derived Dopaminergic Grafts Alleviate L-DOPA Induced Dyskinesia","volume":"12","author":"Elabi","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.stemcr.2026.102818_bib15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.mcn.2008.07.007","article-title":"Neural precursor cells inhibit multiple inflammatory signals","volume":"39","author":"Fainstein","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.stemcr.2026.102818_bib16","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1212\/WNL.0b013e3181bbff1c","article-title":"Pathologic findings in retinal pigment epithelial cell implantation for Parkinson disease","volume":"73","author":"Farag","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.stemcr.2026.102818_bib17","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJM199211263272202","article-title":"Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson\u2019s disease","volume":"327","author":"Freed","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.stemcr.2026.102818_bib18","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of Embryonic Dopamine Neurons for Severe Parkinson\u2019s Disease","volume":"344","author":"Freed","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.stemcr.2026.102818_bib19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ana.410380307","article-title":"Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson\u2019s disease","volume":"38","author":"Freeman","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.stemcr.2026.102818_bib20","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1172\/JCI58767","article-title":"Identification of embryonic stem cell\u2013derived midbrain dopaminergic neurons for engraftment","volume":"122","author":"Ganat","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.stemcr.2026.102818_bib21","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.stem.2014.09.017","article-title":"Human ESC-Derived Dopamine Neurons Show Similar Preclinical Efficacy and Potency to Fetal Neurons when Grafted in a Rat Model of Parkinson\u2019s Disease","volume":"15","author":"Grealish","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stemcr.2026.102818_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cells12071012","article-title":"Microglia Mediated Neuroinflammation in Parkinson\u2019s Disease","volume":"12","author":"Isik","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.stemcr.2026.102818_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/jamaneurol.2013.4749","article-title":"Long-term Clinical Outcome of Fetal Cell Transplantation for Parkinson Disease Two Case Reports","volume":"71","author":"Kefalopoulou","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.stemcr.2026.102818_bib24","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nature23664","article-title":"Human iPS cell-derived dopaminergic neurons function in a primate Parkinson\u2019s disease model","volume":"548","author":"Kikuchi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2026.102818_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.636081","article-title":"Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO","volume":"12","author":"Kim","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.stemcr.2026.102818_bib26","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3389\/fcell.2020.00729","article-title":"Pluripotent Stem Cell Therapies for Parkinson Disease: Present Challenges and Future Opportunities","volume":"8","author":"Kim","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.stemcr.2026.102818_bib27","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.celrep.2012.04.009","article-title":"Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions","volume":"1","author":"Kirkeby","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.stemcr.2026.102818_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.stem.2024.12.005","article-title":"Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update","volume":"32","author":"Kirkeby","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stemcr.2026.102818_bib29","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.stem.2023.08.014","article-title":"Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson\u2019s disease, STEM-PD","volume":"30","author":"Kirkeby","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stemcr.2026.102818_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.stem.2016.09.004","article-title":"Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson\u2019s Disease","volume":"20","author":"Kirkeby","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stemcr.2026.102818_bib31","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/brain\/awad322","article-title":"Neuroinflammation is linked to dementia risk in Parkinson\u2019s disease","volume":"147","author":"Kouli","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.stemcr.2026.102818_bib32","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature10648","article-title":"Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson\u2019s disease","volume":"480","author":"Kriks","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2026.102818_bib33","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature10648","article-title":"Floor plate-derived dopamine neurons from hESCs efficiently engraft in animal models of PD","volume":"480","author":"Kriks","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2026.102818_bib34","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1073\/pnas.1605245113","article-title":"Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain","volume":"113","author":"Li","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.stemcr.2026.102818_bib35","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1126\/science.2105529","article-title":"Grafts of fetal dopamine neurons survive and improve motor function in Parkinson\u2019s disease","volume":"247","author":"Lindvall","year":"1990","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.stemcr.2026.102818_bib36","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archneur.1989.00520420033021","article-title":"Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson\u2019s disease. A detailed account of methodology and a 6-month follow-up","volume":"46","author":"Lindvall","year":"1989","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.stemcr.2026.102818_bib37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/ana.410350208","article-title":"Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson\u2019s disease","volume":"35","author":"Lindvall","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.stemcr.2026.102818_bib38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.scr.2013.01.001","article-title":"Human neural stem\/progenitor cells derived from embryonic stem cells and fetal nervous system present differences in immunogenicity and immunomodulatory potentials in vitro","volume":"10","author":"Liu","year":"2013","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.stemcr.2026.102818_bib39","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1056\/NEJM198704023161402","article-title":"Open Microsurgical Autograft of Adrenal Medulla to the Right Caudate Nucleus in Two Patients with Intractable Parkinson\u2019s Disease","volume":"316","author":"Madrazo","year":"1987","journal-title":"N. Engl. J. Med. Overseas. Ed."},{"key":"10.1016\/j.stemcr.2026.102818_bib40","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3171\/jns.2002.96.3.0589","article-title":"Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: A pilot study. Report of three cases","volume":"96","author":"Mendez","year":"2002","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.stemcr.2026.102818_bib41","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3171\/jns.2000.92.5.0863","volume":"92","author":"Mendez","year":"2000","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.stemcr.2026.102818_bib42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1479-5876-7-53","article-title":"Retinal pigment epithelial cells secrete neurotrophic factors and synthesize dopamine: Possible contribution to therapeutic effects of RPE cell transplantation in Parkinson\u2019s disease","volume":"7","author":"Ming","year":"2009","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.stemcr.2026.102818_bib43","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/jnnp.2006.106021","article-title":"Carotid body autotransplantation in Parkinson disease: A clinical and positron emission tomography study","volume":"78","author":"M\u00ednguez-Castellanos","year":"2007","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.stemcr.2026.102818_bib44","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.stemcr.2013.08.007","article-title":"Direct Comparison of Autologous and Allogeneic Transplantation of iPSC-Derived Neural Cells in the Brain of a Nonhuman Primate","volume":"1","author":"Morizane","year":"2013","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.stemcr.2026.102818_bib45","doi-asserted-by":"crossref","first-page":"937","DOI":"10.5966\/sctm.2016-0073","article-title":"Efficiently Specified Ventral Midbrain Dopamine Neurons from Human Pluripotent Stem Cells Under Xeno-Free Conditions Restore Motor Deficits in Parkinsonian Rodents","volume":"6","author":"Niclis","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.stemcr.2026.102818_bib46","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.stemcr.2020.08.013","article-title":"Direct Reprogramming of Human Fetal- and Stem Cell-Derived Glial Progenitor Cells into Midbrain Dopaminergic Neurons","volume":"15","author":"Nolbrant","year":"2020","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.stemcr.2026.102818_bib47","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1038\/nprot.2017.078","article-title":"Generation of high-purity human ventral midbrain dopaminergic progenitors for in vitro maturation and intracerebral transplantation","volume":"12","author":"Nolbrant","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.stemcr.2026.102818_bib48","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.10720","article-title":"A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson\u2019s disease","volume":"54","author":"Olanow","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.stemcr.2026.102818_bib49","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/archneur.1990.00530120030006","article-title":"Autologous Transplantation of Adrenal Medulla in Parkinson\u2019s Disease: 18-Month Results","volume":"47","author":"Olanow","year":"1990","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.stemcr.2026.102818_bib50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.stem.2023.11.009","article-title":"Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson\u2019s disease","volume":"31","author":"Park","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stemcr.2026.102818_bib51","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41586-023-06300-4","article-title":"Co-transplantation of autologous Treg cells in a cell therapy for Parkinson\u2019s disease","volume":"619","author":"Park","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2026.102818_bib52","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/ejn.14109","article-title":"Cell-based therapy for Parkinson\u2019s disease: A journey through decades toward the light side of the Force","volume":"49","author":"Parmar","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.stemcr.2026.102818_bib53","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.stem.2025.03.008","article-title":"A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models","volume":"32","author":"Pavan","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stemcr.2026.102818_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-021-02237-4","article-title":"Immunological considerations and challenges for regenerative cellular therapies","volume":"4","author":"Petrus-Reurer","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.stemcr.2026.102818_bib55","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/16060","article-title":"Dopamine release from nigral transplants visualized in vivo in a Parkinson\u2019s patient","volume":"2","author":"Piccini","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.stemcr.2026.102818_bib56","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nature01552","article-title":"Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis","volume":"422","author":"Pluchino","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2026.102818_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005959","article-title":"Immune Regulatory Neural Stem\/Precursor Cells Protect from Central Nervous System Autoimmunity by Restraining Dendritic Cell Function","volume":"4","author":"Pluchino","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.stemcr.2026.102818_bib58","doi-asserted-by":"crossref","DOI":"10.1042\/NS20200083","article-title":"The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson\u2019s disease","volume":"5","author":"Qarin","year":"2021","journal-title":"Neuronal Signal."},{"key":"10.1016\/j.stemcr.2026.102818_bib59","first-page":"325","article-title":"Cellular replacement of dopamine deficit in Parkinson\u2019s disease using human fetal mesencephalic tissue: Preliminary results in four patients","volume":"71","author":"Redmond","year":"1993","journal-title":"Res. Publ. Assoc. Res. Nerv. Ment. Dis."},{"key":"10.1016\/j.stemcr.2026.102818_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.00428","article-title":"Transplantation of Neural Precursor Cells Attenuates Chronic Immune Environment in Cervical Spinal Cord Injury","volume":"9","author":"Riemann","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.stemcr.2026.102818_bib61","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/cells11010024","article-title":"Pluripotent Stem Cell-Derived Hepatocytes Inhibit T Cell Proliferation In Vitro through Tryptophan Starvation","volume":"11","author":"Romano","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.stemcr.2026.102818_bib62","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41586-025-08700-0","article-title":"Phase I\/II trial of iPS-cell-derived dopaminergic cells for Parkinson\u2019s disease","volume":"641","author":"Sawamoto","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2026.102818_bib63","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","article-title":"Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson\u2019s Disease","volume":"382","author":"Schweitzer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.stemcr.2026.102818_bib64","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/bs.pbr.2017.02.008","article-title":"Strategies for bringing stem cell-derived dopamine neurons to the clinic-The NYSTEM trial","volume":"230","author":"Studer","year":"2017","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.stemcr.2026.102818_bib65","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41586-025-08845-y","article-title":"Phase I trial of hES cell-derived dopaminergic neurons for Parkinson\u2019s disease","volume":"641","author":"Tabar","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2026.102818_bib66","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.reth.2020.06.002","article-title":"iPS cell-based therapy for Parkinson\u2019s disease: A Kyoto trial","volume":"13","author":"Takahashi","year":"2020","journal-title":"Regen. Ther."},{"key":"10.1016\/j.stemcr.2026.102818_bib67","article-title":"Single cell transcriptomics identifies stem cell-derived graft composition in a model of Parkinson\u2019s disease","volume":"11","author":"Tiklov\u00e1","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stemcr.2026.102818_bib68","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ana.410420115","article-title":"Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson\u2019s disease","volume":"42","author":"Wenning","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.stemcr.2026.102818_bib69","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1056\/NEJM199211263272203","article-title":"Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"327","author":"Widner","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.stemcr.2026.102818_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.590960","article-title":"Harnessing the Neural Stem Cell Secretome for Regenerative Neuroimmunology","volume":"14","author":"Willis","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.stemcr.2026.102818_bib71","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1242\/dev.098145","article-title":"Cxcl12\/Cxcr4 signaling controls the migration and process orientation of A9-A10 dopaminergic neurons","volume":"140","author":"Yang","year":"2013","journal-title":"Development"},{"key":"10.1016\/j.stemcr.2026.102818_bib72","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12946","article-title":"Generation of universal and hypoimmunogenic human pluripotent stem cells","volume":"53","author":"Ye","year":"2020","journal-title":"Cell Prolif."}],"container-title":["Stem Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213671126000299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213671126000299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:59:42Z","timestamp":1773154782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213671126000299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2213671126000299"],"URL":"https:\/\/doi.org\/10.1016\/j.stemcr.2026.102818","relation":{},"ISSN":["2213-6711"],"issn-type":[{"value":"2213-6711","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immunological profile of RC17 hESC-derived dopaminergic neural progenitor cells in vitro: Implications for the STEM-PD clinical trial","name":"articletitle","label":"Article Title"},{"value":"Stem Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.stemcr.2026.102818","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Stem Cell Research.","name":"copyright","label":"Copyright"}],"article-number":"102818"}}